Share Richard Bernstein, MD, PhD - Factoring a Balanced Efficacy and Safety Profile Into the Equation: Exploring FXIa Inhibitors in Stroke Prevention

Copy link

June 18, 2024

Richard Bernstein, MD, PhD - Factoring a Balanced Efficacy and Safety Profile Into the Equation: Exploring FXIa Inhibitors in Stroke Prevention

14 minutes

Please visit answersincme.com/XFG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in vascular neurology discusses the data and the implications for inhibiting coagulation factor XIa (FXIa) as a therapeutic option in stroke prevention. Upon completion of this activity, participants should be better able to: Identify the rationale for inhibiting FXIa as a therapeutic option in stroke prevention; Describe the latest clinical data for oral FXIa inhibitors in stroke prevention; and Review the implications of the latest FXIa inhibitor data for the future of stroke prevention.

...more